References: 

• 1. Crick FHC (1956) Ideas on protein synthesis. Wellcome Library for the History and Understanding of Medicine. Avaiable from: http://archives.wellcome.ac.uk/.
• 2. Crick FHC (1970) Central Dogma of Molecular Biology. Nature 227: 561–563.    
• 3. Baltimore D (1970) RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226: 1209–1211.    
• 4. Temin HM, Mizutani S (1970) RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226: 1211–1213.    
• 5. Koonin EV (2012) Does the central dogma still stand? Biol Direct 7: 27.    
• 6. Melnikov S, Ben-Shem A, Garreau de Loubresse N, et al. (2012) One core, two shells: bacterial and eukaryotic ribosomes. Nat Struct Mol Biol 19: 560–567.    
• 7. Khatter H, Myasnikov AG, Natchiar SK, et al. (2015) Structure of the human 80S ribosome. Nature 520: 640–645.    
• 8. Kolitz SE, Lorsch JR (2010) Eukaryotic initiator tRNA: finely tuned and ready for action. FEBS Lett 584: 396–404.    
• 9. Rodnina MV (2016) The ribosome in action: Tuning of translational efficiency and protein folding. Protein Sci 25: 1390–1406.    
• 10. Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2015) Translational readthrough potential of natural termination codons in eucaryotes--The impact of RNA sequence. RNA Biol 12: 950–958.    
• 11. Karpinets TV, Greenwood DJ, Sams CE, et al. (2006) RNA:protein ratio of the unicellular organism as a characteristic of phosphorous and nitrogen stoichiometry and of the cellular requirement of ribosomes for protein synthesis. BMC Biol 4: 1–10.    
• 12. Ingolia NT, Lareau LF, Weissman JS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147: 789–802.    
• 13. Dennis PP, Bremer H (1974) Differential Rate of Ribosomal Protein Synthesis in Escherichia coli B/r. J Mol Biol 84: 407–422.    
• 14. Dennis PP, Nomura M (1974) Stringent Control of Ribosomal Protein Gene Expression in Escherichia coli. Proc Nat Acad Sci USA 71: 3819–3823.    
• 15. Young R, Bremer H (1976) Polypeptide-Chain-Elongation Rate in Escherichia coli B/r as a Function ofGrowth Rate. Biochem J 160: 185–194.    
• 16. Schaaper RM (1993) Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J Biol Chem 268: 23762–23765.
• 17. Drake JW, Charlesworth B, Charlesworth D, et al. (1998) Rates of spontaneous mutation. Genetics 148: 1667–1686.
• 18. Kunkel TA (2004) DNA replication fidelity. J Biol Chem 279: 16895–16898.    
• 19. Bebenek K, Kunkel TA (2004) Functions of DNA polymerases. Adv Protein Chem 69: 137–165.    
• 20. Kunkel TA (2009) Evolving Views of DNA Replication (In)Fidelity. Cold Spring Harb Sym 74: 91–101.    
• 21. Sainsbury S, Bernecky C, Cramer P (2015) Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol 16: 129–143.    
• 22. Sharma N (2016) Regulation of RNA polymerase II-mediated transcriptional elongation: Implications in human disease. IUBMB Life 68: 709–716.    
• 23. Loya TJ, Reines D (2016) Recent advances in understanding transcription termination by RNA polymerase II. F1000 Res 5: 1478.
• 24. Schwanhausser B, Busse D, Li N, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337–342.    
• 25. Imashimizu M, Oshima T, Lubkowska L, et al. (2013) Direct assessment of transcription fidelity by high-resolution RNA sequencing. Nucleic Acids Res 41: 9090–9104.    
• 26. Ninio J (1991) Connections between translation, transcription and replication error-rates. Biochimie 73: 1517–1523.    
• 27. Gouta JF, Thomasb WK, Smithc Z, et al. (2013) Large-scale detection of in vivo transcription errors. PNAS 110: 18584–18589.    
• 28. Cochella L, Green R (2005) Fidelity in protein synthesis. Curr Biol 15: 536–540.    
• 29. Kramer EB, Farabaugh PJ (2007) The frequency of translational misreading errors in E. coli is largely determined by tRNA competition. RNA 13: 87–96.
• 30. Zaher HS, Green R (2009) Fidelity at the molecular level: lessons from protein synthesis. Cell 136: 746–762.    
• 31. Gingold H, Pilpel Y (2011) Determinants of translation efficiency and accuracy. Mol Syst Biol 7: 141–150.
• 32. Ribas de Pouplana L, Santos MA, Zhu JH, et al. (2014) Protein mistranslation: friend or foe? Trends Biochem Sci 39: 355–362.    
• 33. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181: 223–230.    
• 34. Bulik S, Peters B, Holzhutter HG (2005) Quantifying the Contribution of Defective Ribosomal Products to Antigen Production: A Model-Based Computational Analysis. J Immunol 175: 7957–7964.    
• 35. Vabulas RM, Hartl FU (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310: 1960–1963.    
• 36. Schubert U, Antón LC, Gibbs J, et al. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770–774.    
• 37. Vabulas RM, Hartl UF (2005) Protein Synthesis upon Acute Nutrient Restriction Relies on Proteasome Function. Science 310: 1960–1963.    
• 38. Hung MC, Link W (2011) Protein localization in disease and therapy. J Cell Sci 124: 3381–3392.
• 39. Chacinska A, Koehler CM, Milenkovic D, et al. (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138: 628–644.    
• 40. Rapoport TA (2007) Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450: 663–669.    
• 41. Geva Y, Schuldiner M (2014) The back and forth of cargo exit from the endoplasmic reticulum. Curr Biol 24: 130–136.    
• 42. Barlowe C, Helenius A (2016) Cargo Capture and Bulk Flow in the Early Secretory Pathway. Annu Rev Cell Dev Biol 32: 197–222.    
• 43. Herrmann JM, Neupert W (2000) Protein transport into mitochondria. Curr Opin Microbiol 3: 210–214.    
• 44. Zimmermann R, Eyrisch S, Ahmad M, et al. (2011) Protein translocation across the ER membrane. Biochim Biophys Acta 1808: 912–924.    
• 45. Freitas N, Cunha C (2009) Mechanisms and signals for the nuclear import of proteins. Curr Genomics 10: 550–557.    
• 46. Nichols WC, Seligsohn U, Zivelin A, et al. (1998) Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93: 61–70.    
• 47. Spreafico M, Peyvandi F (2009) Combined Factor V and Factor VIII Deficiency. Semin Thromb Hemost 35: 390–399.    
• 48. Rock KL, Gramm C, Rothstein L, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761–771.    
• 49. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895–899.    
• 50. Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477–513.    
• 51. Rock KL, Farfan-Arribas DJ, Colbert JD, et al. (2014) Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol 35: 144–152.    
• 52. Cohen-Kaplan V, Livneh I, Avni N, et al. (2016) The ubiquitin-proteasome system and autophagy: Coordinated and independent activities. Int J Biochem Cell Biol: In Press.
• 53. Ravikumar B, Sarkar S, Davies JE, et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383–1435.    
• 54. Mariappan M, Li X, Stefanovic S, et al. (2010) A ribosome-associating factor chaperones tail-anchored membrane proteins. Nature 466: 1120–1124.    
• 55. Brandman O, Stewart-Ornstein J, Wong D, et al. (2012) A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151: 1042–1054.    
• 56. Defenouillère Q, Yao Y, Mouaikel J, et al. (2013) Cdc48 associated complex bound to 60s particles is required for the clearance of aberrant translation products. PNAS 110: 5046–5051.    
• 57. Shao S, von der Malsburg K, Hegde RS (2013) Listerin-dependent nascent protein ubiquitination relies on ribosome subunit dissociation. Mol Cell 50: 637–648.    
• 58. Verma R, Oania RS, Kolawa1 NJ, et al. (2013) Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2: e00308.
• 59. Shen PS, Park J, Qin Y, et al. (2016) Rqc2p and 60S ribosomal subunits mediate mRNA-independent elongation of nascent chains. Science 347: 75–78.
• 60. Ghaemmaghami S, Huh WK, Bower K, et al. (2003) Global analysis of protein expression in yeast. Nature 425: 737–741.    
• 61. Schwarz F, Aebi M (2011) Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 21: 576–582.    
• 62. Tannous A, Pisoni GB, Hebert DN, et al. (2015) N-linked sugar-regulated protein folding and quality control in the ER. Semin Cell Dev Biol 41: 79–89.    
• 63. Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286: 1882–1888.    
• 64. Aebi M, Bernasconi R, Clerc S, et al. (2010) N-glycan structures: recognition and processing in the ER. Trends Biochem Sci 35: 74–82.    
• 65. Schallus T, Feher K, Sternberg U, et al. (2010) Analysis of the specific interactions between the lectin domain of malectin and diglucosides. Glycobiology 20: 1010–1020.    
• 66. Galli C, Bernasconi R, Solda T, et al. (2011) Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. PLoS One 6: e16304.    
• 67. Pisoni GB, Ruddock LW, Bulleid N, et al. (2015) Division of labor among oxidoreductases: TMX1 preferentially acts on transmembrane polypeptides. Mol Biol Cell 26: 3390–3400.    
• 68. Lamriben L, Graham JB, Adams BM, et al. (2016) N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle. Traffic 17: 308–326.    
• 69. Cabral CM, Choudhury P, Liu Y, et al. (2000) Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem 275: 25015–25022.    
• 70. Olivari S, Cali T, Salo KE, et al. (2006) EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. Biochem Biophys Res Commun 349: 1278–1284.    
• 71. Ninagawa S, Okada T, Sumitomo Y, et al. (2014) EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step. J Cell Biol 206: 347–356.    
• 72. Hirao K, Natsuka Y, Tamura T, et al. (2006) EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J Biol Chem 281: 9650–9658.    
• 73. Olivari S, Molinari M (2007) Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins. FEBS Lett 581: 3658–3664.    
• 74. Christianson JC, Shaler TA, Tyler RE, et al. (2008) OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat Cell Biol 10: 272–282.    
• 75. Bernasconi R, Galli C, Calanca V, et al. (2010) Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates. J Cell Biol 188: 223–235.    
• 76. Vembar SS, Brodsky JL (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944–957.    
• 77. Merulla J, Solda T, Molinari M (2015) A novel UGGT1 and p97-dependent checkpoint for native ectodomains with ionizable intramembrane residue. Mol Biol Cell 26: 1532–1542.    
• 78. Merulla J, Fasana E, Solda T, et al. (2013) Specificity and regulation of the endoplasmic reticulum-associated degradation machinery. Traffic 14: 767–777.    
• 79. Bernasconi R, Molinari M (2011) ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr Opin Cell Biol 23: 176–183.    
• 80. Koenig PA, Nicholls PK, Schmidt FI, et al. (2014) The E2 ubiquitin-conjugating enzyme UBE2J1 is required for spermiogenesis in mice. J Biol Chem 289: 34490–34502.    
• 81. Hagiwara M, Ling J, Koenig PA, et al. (2016) Posttranscriptional Regulation of Glycoprotein Quality Control in the Endoplasmic Reticulum Is Controlled by the E2 Ub-Conjugating Enzyme UBC6e. Mol Cell 63: 753–767.    
• 82. Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221: 3–12.    
• 83. Mizushima N, Ohsumi Y, Yoshimori T (2002) Autophagosome Formation in Mammalian Cells. Cell Struct Funct 27: 421–429.    
• 84. Ohsumi Y (2014) Historical landmarks of autophagy research. Cell Res 24: 9–23.    
• 85. Ariosa AR, Klionsky DJ (2016) Autophagy core machinery: overcoming spatial barriers in neurons. J Mol Med (Berl): In Press.
• 86. Ryter SW, Cloonan SM, Choi AM (2013) Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 36: 7–16.    
• 87. Choi AM, Ryter SW, Levine B (2013) Autophagy in human health and disease. N Engl J Med 368: 1845–1846.    
• 88. Lin F, Qin ZH (2013) Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment? J Huntingtons Dis 2: 149–157.
• 89. Webb JL, Ravikumar B, Atkins J, et al. (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278: 25009–25013.    
• 90. Pickford F, Masliah E, Britschgi M, et al. (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118: 2190–2199.
• 91. Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105: 49–59.    
• 92. Perlmutter DH (2011) Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates. Annu Rev Med 62: 333–345.    
• 93. Fu L, Sztul E (2009) ER-associated complexes (ERACs) containing aggregated cystic fibrosis transmembrane conductance regulator (CFTR) are degraded by autophagy. Eur J Cell Biol 88: 215–226.    
• 94. Farre JC, Subramani S (2016) Mechanistic insights into selective autophagy pathways: lessons from yeast. Nat Rev Mol Cell Biol 17: 537–552.
• 95. Khaminets A, Heinrich T, Mari M, et al. (2015) Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522: 354–358.    
• 96. Fumagalli FNJ, Bergmann TJ, Cebollero E, et al. (2016) Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat Cell Biol: In press.
• 97. Inoue T, Tsai B (2013) How viruses use the endoplasmic reticulum for entry, replication, and assembly. Cold Spring Harb Perspect Biol 5: a013250.    
• 98. van den Boomen DJ, Lehner PJ (2015) Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I. Mol Immunol 68: 106–111.    
• 99. Gardner BM, Pincus D, Gotthardt K, et al. (2013) Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol 5: a013169.
• 100. Mori K (2009) Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146: 743–750.    
• 101. Zhang L, Zhang C, Wang A (2016) Divergence and Conservation of the Major UPR Branch IRE1-bZIP Signaling Pathway across Eukaryotes. Sci Rep 6: 27362.    
• 102. Lee AH, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23: 7448–7459.    
• 103. Hollien J, Weissman JS (2006) Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313: 104–107.    
• 104. Haze K, Yoshida H, Yanagi H, et al. (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10: 3787–3799.    
• 105. Shoulders MD, Ryno LM, Genereux JC, et al. (2013) Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep 3: 1279–1292.    
• 106. Bertolotti A, Zhang Y, Hendershot LM, et al. (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2: 326–332.    
• 107. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271–274.    
• 108. Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101: 11269–11274.    
• 109. Lu PD, Harding HP, Ron D (2004) Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 167: 27–33.    
• 110. Jiang HY, Wek SA, McGrath BC, et al. (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24: 1365–1377.    
• 111. Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569: 29–63.    
• 112. Redler RL, Das J, Diaz JR, et al. (2016) Protein Destabilization as a Common Factor in Diverse Inherited Disorders. J Mol Evol 82: 11–16.    
• 113. Sitia R, Braakman I (2003) Quality control in the endoplasmic reticulum protein factory. Nature 426: 891–894.    
• 114. Bernier V, Lagace M, Bichet DG, et al. (2004) Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol Metab 15: 222–228.    
• 115. Molinari M (2007) N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 3: 313–320.    
• 116. Kopito RR, Ron D (2000) Conformational disease. Nat Cell Biol 2: 207–209.    
• 117. Gidalevitz T, Ben-Zvi A, Ho KH, et al. (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471–1474.    
• 118. Powers ET, Morimoto RI, Dillin A, et al. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78: 959–991.    
• 119. Morello JP, Petaja-Repo UE, Bichet DG, et al. (2000) Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 21: 466–469.    
• 120. Cohen FE, Kelly JW (2003) Therapeutic approaches to protein-misfolding diseases. Nature 426: 905–909.    
• 121. Convertino M, Das J, Dokholyan NV (2016) Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases. ACS Chem Biol 11: 1471–1489.    
• 122. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4: 966–977.    
• 123. Fernandez PM, Tabbara SO, Jacobs LK, et al. (2000) Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 59: 15–26.    
• 124. Shuda M, Kondoh N, Imazeki N, et al. (2003) Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38: 605–614.
• 125. Song MS, Park YK, Lee JH, et al. (2001) Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res 61: 8322–8330.
• 126. Gazit G, Lu J, Lee AS (1999) De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 54: 135–146.    
• 127. Plate L, Paxman RJ, Wiseman RL, et al. (2016) Modulating protein quality control. Elife 5: e18431.
• 128. Wang X, Venable J, LaPointe P, et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127: 803–815.    
• 129. Mu TW, Ong DS, Wang YJ, et al. (2008) Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134: 769–781.    
• 130. Chiang WC, Hiramatsu N, Messah C, et al. (2012) Selective activation of ATF6 and PERK endoplasmic reticulum stress signaling pathways prevent mutant rhodopsin accumulation. Invest Ophthalmol Vis Sci 53: 7159–7166.    
• 131. Luheshi LM, Dobson CM (2009) Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 583: 2581–2586.    
• 132. Braakman I, Bulleid NJ (2011) Protein folding and modification in the mammalian endoplasmic reticulum. Annu Rev Biochem 80: 71–99.    
• 133. Brodsky JL, Skach WR (2011) Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr Opin Cell Biol 23: 464–475.    
• 134. Papa FR, Zhang C, Shokat K, et al. (2003) Bypassing a kinase activity with an ATP-competitive drug. Science 302: 1533–1537.    
• 135. Wiseman RL, Zhang Y, Lee KP, et al. (2010) Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol Cell 38: 291–304.    
• 136. Wang L, Perera BG, Hari SB, et al. (2012) Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors. Nat Chem Biol 8: 982–989.    
• 137. Sidrauski C, Tsai JC, Kampmann M, et al. (2015) Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. Elife 4: e07314.
• 138. Robblee MM, Kim CC, Porter Abate J, et al. (2016) Saturated Fatty Acids Engage an IRE1alpha-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. Cell Rep 14: 2611–2623.    
• 139. Gallagher CM, Walter P (2016) Ceapins inhibit ATF6alpha signaling by selectively preventing transport of ATF6alpha to the Golgi apparatus during ER stress. Elife 5: e11880.
• 140. Gallagher CM, Garri C, Cain EL, et al. (2016) Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6alpha branch. Elife 5: e11880.
• 141. Plate L, Cooley CB, Chen JJ, et al. (2016) Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. Elife 5: e15550.
• 142. Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262–1278.    

show all references